The
GE81112 complex has garnered much interest due to its broad
antimicrobial properties and unique ability to inhibit bacterial translation
initiation. Herein we report the use of a chemoenzymatic strategy
to complete the first total synthesis of GE81112 B1. By pairing iron
and α-ketoglutarate dependent hydroxylases found in GE81112
biosynthesis with traditional synthetic methodology, we were able
to access the natural product in 11 steps (longest linear sequence).
Following this strategy, 10 GE81112 B1 analogues were synthesized,
allowing for identification of its key pharmacophores. A key feature
of our medicinal chemistry effort is the incorporation of additional
biocatalytic hydroxylations in modular analogue synthesis to rapidly
enable exploration of relevant chemical space.